Although there is no known direct impact of obesity on CD47 levels, obesity is associated with an increased risk of diabetes and other ageing-related conditions such as hypertension, which may result in elevated COVID-19 vulnerability [4]. This evidence concerns the gene CD47 and obesity due to melanocortin 4 receptor deficiency.